AMERICAN JOURNAL OF OPHTHALMOLOGY, vol.151, no.2, pp.303-309, 2011 (SCI-Expanded)
PURPOSE: To evaluate the effect of half-dose verteporfin photodynamic therapy (PDT) on macular function in cases of central serous chorioretinopathy (CSC).